Japan's ministry of health, labour and welfare approves csl and arcturus therapeutics' arct-154, the first self-amplifying mrna vaccine approved for covid in adults

Exclusive partner in japan, meiji seika pharma  advances regulatory approval this historic approval of the world's first self-amplifying messenger rna (sa-mrna) covid-19 vaccine underscores csl's promise to develop and deliver innovations when there is a public health need first marketing approval milestone for csl and arcturus therapeutics since closing the global collaboration and licensing agreement in 2022 with the approval of arct-154, csl now offers an even more comprehensive portfolio of innovative vaccines that combat respiratory viral diseases. king of prussia, pa.
ARCT Ratings Summary
ARCT Quant Ranking